Jacqueline A. Brosnan‐Cashman

Author

Also Known As

J BROSNAN, J Brosnan, J Brosnan-Cashman, J. Brosnan, J. Brosnan-Cashman, Jacqueline A Brosnan, Jacqueline A. Brosnan, Jacqueline A. Brosnan-Cashman, Jacqueline A. Brosnan‐Cashman, Jacqueline Brosnan-Cashman

121

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center University of Michigan Cancer Research Center

About

Jacqueline A. Brosnan‐Cashman is an author at Johns Hopkins University specializing in medicine, pathology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	229
2	Pathology	5	5	159
3	Cell Biology	4	4	177
4	Neurology	1	1	35
5	Surgical Oncology	1	1	17

Jacqueline A. Brosnan‐Cashman

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma Carl Koschmann, Anda‐Alexandra Calinescu, Felipe J. Núñez, Science Translational Medicine	2016	297
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response Felipe J. Núñez, Flor Mendez, Padma Kadiyala, Science Translational Medicine	2019	283
Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors Shinichi Yachida, Catherine M. White, Yoshiki Naito, Clinical Cancer Research	2012	269
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma Bill H. Diplas, Xujun He, Jacqueline A. Brosnan‐Cashman, Nature Communications	2018	175
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival Joo Young Kim, Jacqueline A. Brosnan‐Cashman, Soyeon An, Clinical Cancer Research	2016	143
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size Wenzel M. Hackeng, Lodewijk A.A. Brosens, Joo Young Kim, Gut	2021	138
Alternative lengthening of telomeres, ATRX loss and H3‐K27M mutations in histologically defined pilocytic astrocytoma with anaplasia Fausto J. Rodríguez, Jacqueline A. Brosnan‐Cashman, Sariah J. Allen, Brain Pathology	2018	71
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization Tingting Qin, Brendan Mullan, Ramya Ravindran, Cell Reports Atrx-deficient Gbm CellsCell CycleHigh-grade GliomasGliomaTumor Biology	2022	70
ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner Jacqueline A. Brosnan‐Cashman, Ming Yuan, Mindy K. Graham, PLoS ONE Tumor BiologyGenome InstabilityTelomere Length MaintenanceGliomaCell Line-specific Manner	2018	68
Genetically Defined Subsets of Human Pancreatic Cancer Show Unique <i>In Vitro</i> Chemosensitivity Yunfeng Cui, Jacqueline A. Brosnan‐Cashman, Amanda L. Blackford, Clinical Cancer Research	2012	65

Page 1